The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region-Reference-Cited by-同舟云学术

The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region

Published:2023-07-26 Issue:8 Volume:23 Page:671-677
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Alkhatib Nimer S¹²³^ORCID,Halloush Shiraz⁴,Abraham Ivo²⁵

Affiliation:

1. Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan

2. Center for Health Outcomes and PharmacoEconomic Evaluation, University of Arizona, Tucson, AZ, USA

3. Pi Pharma Intelligence, LLC, Amman, Jordan

4. Faculty of Pharmacy, Applied Science Private University, Amman, Jordan

5. Matrix45, LLC, Tucson, Arizona

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2023.2241346

Reference25 articles.

1. Explaining biosimilars and how reverse engineering plays a critical role in their development

2. Ten years of biosimilars in Europe: development and evolution of the regulatory pathways

3. Medicare Part B Drug Average Sales Price, Center for Medicare and Medicaid Services; 2023. [cited 2023 Mar 22]. Available from: https://www.cms.gov/medicare/medicare-fee-for-service-part-b-drugs/mcrpartbdrugavgsalesprice.

4. The Coming of Age of Biosimilars: A Personal Perspective

5. Chen Y, Monnard A, da Silva JS An Inflection Point for Biosimilars; 2021. [cited 2023 Mar 22] Available from: https://www.mckinsey.com/industries/life-sciences/our-insights/an-inflection-point-for-biosimilars

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States;Pharmacy;2024-06-16

2. Preparing for the third decade of biosimilars;Expert Opinion on Biological Therapy;2023-08-03